Report Detail
Global Budesonide Capsules Market Insights, Forecast to 2025
- RnM3498616 |
- 06 June, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Budesonide is a first-line anti-inflammatory agent and locally acting glucocorticosteroid indicated for the induction and maintenance of remission of mild to moderate ileocaecal Crohn's disease (capsules) and ulcerative colitis (enemas) as well as for the remission of active microscopic colitis (capsules).
The global Budesonide Capsules market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Budesonide Capsules market based on company, product type, end user and key regions.
This report studies the global market size of Budesonide Capsules in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Budesonide Capsules in these regions.
This research report categorizes the global Budesonide Capsules market by top players/brands, region, type and end user. This report also studies the global Budesonide Capsules market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Perrigo
Mylan
Tillotts Pharma
Teva
Zydus Pharmaceuticals
Amneal
Mayne Pharma
Sciecure Pharma
Market size by Product
Entocort Capsules
Generic of Entocort
Market size by End User
Crohn's disease
Collagenous colitis
Autoimmune hepatitis
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Budesonide Capsules market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Budesonide Capsules market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Budesonide Capsules companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Budesonide Capsules submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Budesonide Capsules are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Budesonide Capsules market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Budesonide Capsules Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Budesonide Capsules Market Size Growth Rate by Product
- 1.4.2 Entocort Capsules
- 1.4.3 Generic of Entocort
- 1.5 Market by End User
- 1.5.1 Global Budesonide Capsules Market Size Growth Rate by End User
- 1.5.2 Crohn's disease
- 1.5.3 Collagenous colitis
- 1.5.4 Autoimmune hepatitis
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Budesonide Capsules Market Size
- 2.1.1 Global Budesonide Capsules Revenue 2014-2025
- 2.1.2 Global Budesonide Capsules Sales 2014-2025
- 2.2 Budesonide Capsules Growth Rate by Regions
- 2.2.1 Global Budesonide Capsules Sales by Regions
- 2.2.2 Global Budesonide Capsules Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Budesonide Capsules Sales by Manufacturers
- 3.1.1 Budesonide Capsules Sales by Manufacturers
- 3.1.2 Budesonide Capsules Sales Market Share by Manufacturers
- 3.1.3 Global Budesonide Capsules Market Concentration Ratio (CR5 and HHI)
- 3.2 Budesonide Capsules Revenue by Manufacturers
- 3.2.1 Budesonide Capsules Revenue by Manufacturers (2014-2019)
- 3.2.2 Budesonide Capsules Revenue Share by Manufacturers (2014-2019)
- 3.3 Budesonide Capsules Price by Manufacturers
- 3.4 Budesonide Capsules Manufacturing Base Distribution, Product Types
- 3.4.1 Budesonide Capsules Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Budesonide Capsules Product Type
- 3.4.3 Date of International Manufacturers Enter into Budesonide Capsules Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Budesonide Capsules Sales by Product
- 4.2 Global Budesonide Capsules Revenue by Product
- 4.3 Budesonide Capsules Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Budesonide Capsules Breakdown Data by End User
6 North America
- 6.1 North America Budesonide Capsules by Countries
- 6.1.1 North America Budesonide Capsules Sales by Countries
- 6.1.2 North America Budesonide Capsules Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Budesonide Capsules by Product
- 6.3 North America Budesonide Capsules by End User
7 Europe
- 7.1 Europe Budesonide Capsules by Countries
- 7.1.1 Europe Budesonide Capsules Sales by Countries
- 7.1.2 Europe Budesonide Capsules Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Budesonide Capsules by Product
- 7.3 Europe Budesonide Capsules by End User
8 Asia Pacific
- 8.1 Asia Pacific Budesonide Capsules by Countries
- 8.1.1 Asia Pacific Budesonide Capsules Sales by Countries
- 8.1.2 Asia Pacific Budesonide Capsules Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Budesonide Capsules by Product
- 8.3 Asia Pacific Budesonide Capsules by End User
9 Central & South America
- 9.1 Central & South America Budesonide Capsules by Countries
- 9.1.1 Central & South America Budesonide Capsules Sales by Countries
- 9.1.2 Central & South America Budesonide Capsules Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Budesonide Capsules by Product
- 9.3 Central & South America Budesonide Capsules by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Budesonide Capsules by Countries
- 10.1.1 Middle East and Africa Budesonide Capsules Sales by Countries
- 10.1.2 Middle East and Africa Budesonide Capsules Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Budesonide Capsules by Product
- 10.3 Middle East and Africa Budesonide Capsules by End User
11 Company Profiles
- 11.1 Perrigo
- 11.1.1 Perrigo Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Perrigo Budesonide Capsules Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Perrigo Budesonide Capsules Products Offered
- 11.1.5 Perrigo Recent Development
- 11.2 Mylan
- 11.2.1 Mylan Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Mylan Budesonide Capsules Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Mylan Budesonide Capsules Products Offered
- 11.2.5 Mylan Recent Development
- 11.3 Tillotts Pharma
- 11.3.1 Tillotts Pharma Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Tillotts Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Tillotts Pharma Budesonide Capsules Products Offered
- 11.3.5 Tillotts Pharma Recent Development
- 11.4 Teva
- 11.4.1 Teva Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Teva Budesonide Capsules Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Teva Budesonide Capsules Products Offered
- 11.4.5 Teva Recent Development
- 11.5 Zydus Pharmaceuticals
- 11.5.1 Zydus Pharmaceuticals Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Zydus Pharmaceuticals Budesonide Capsules Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Zydus Pharmaceuticals Budesonide Capsules Products Offered
- 11.5.5 Zydus Pharmaceuticals Recent Development
- 11.6 Amneal
- 11.6.1 Amneal Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Amneal Budesonide Capsules Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Amneal Budesonide Capsules Products Offered
- 11.6.5 Amneal Recent Development
- 11.7 Mayne Pharma
- 11.7.1 Mayne Pharma Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Mayne Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Mayne Pharma Budesonide Capsules Products Offered
- 11.7.5 Mayne Pharma Recent Development
- 11.8 Sciecure Pharma
- 11.8.1 Sciecure Pharma Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Sciecure Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Sciecure Pharma Budesonide Capsules Products Offered
- 11.8.5 Sciecure Pharma Recent Development
12 Future Forecast
- 12.1 Budesonide Capsules Market Forecast by Regions
- 12.1.1 Global Budesonide Capsules Sales Forecast by Regions 2019-2025
- 12.1.2 Global Budesonide Capsules Revenue Forecast by Regions 2019-2025
- 12.2 Budesonide Capsules Market Forecast by Product
- 12.2.1 Global Budesonide Capsules Sales Forecast by Product 2019-2025
- 12.2.2 Global Budesonide Capsules Revenue Forecast by Product 2019-2025
- 12.3 Budesonide Capsules Market Forecast by End User
- 12.4 North America Budesonide Capsules Forecast
- 12.5 Europe Budesonide Capsules Forecast
- 12.6 Asia Pacific Budesonide Capsules Forecast
- 12.7 Central & South America Budesonide Capsules Forecast
- 12.8 Middle East and Africa Budesonide Capsules Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Budesonide Capsules Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Budesonide Capsules . Industry analysis & Market Report on Budesonide Capsules is a syndicated market report, published as Global Budesonide Capsules Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Budesonide Capsules market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
